Arrow Financial’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-13,997
Closed -$1.39M 339
2019
Q3
$1.39M Sell
13,997
-757
-5% -$71.9K 0.29% 77
2019
Q2
$1.36M Buy
14,754
+10
+0.1% +$950 0.29% 75
2019
Q1
$1.39M Sell
14,744
-120
-0.8% -$10.5K 0.32% 76
2018
Q4
$953K Sell
14,864
-4,715
-24% -$348K 0.24% 89
2018
Q3
$1.75M Sell
19,579
-551
-3% -$48.7K 0.37% 67
2018
Q2
$1.6M Sell
20,130
-437
-2% -$36.3K 0.36% 72
2018
Q1
$1.83M Sell
20,567
-1,920
-9% -$184K 0.43% 63
2017
Q4
$2.35M Sell
22,487
-822
-4% -$92.8K 0.54% 51
2017
Q3
$3.4M Sell
23,309
-388
-2% -$52.9K 0.81% 34
2017
Q2
$3.08M Sell
23,697
-510
-2% -$62.5K 0.74% 39
2017
Q1
$3.01M Sell
24,207
-1,189
-5% -$142K 0.73% 38
2016
Q4
$2.94M Sell
25,396
-1,049
-4% -$117K 0.73% 38
2016
Q3
$2.76M Sell
26,445
-1,013
-4% -$110K 0.7% 39
2016
Q2
$2.71M Sell
27,458
-5,502
-17% -$569K 0.71% 44
2016
Q1
$3.3M Buy
32,960
+735
+2% +$75.7K 0.88% 33
2015
Q4
$3.86M Sell
32,225
-338
-1% -$39.1K 1.03% 29
2015
Q3
$3.52M Buy
32,563
+620
+2% +$76.9K 1% 29
2015
Q2
$3.7M Sell
31,943
-608
-2% -$69.5K 1% 32
2015
Q1
$3.75M Sell
32,551
-2,946
-8% -$352K 1.01% 30
2014
Q4
$3.97M Buy
35,497
+984
+3% +$104K 1.08% 27
2014
Q3
$3.27M Sell
34,513
-279
-0.8% -$25.2K 0.91% 34
2014
Q2
$2.99M Sell
34,792
-560
-2% -$42.6K 0.81% 34
2014
Q1
$2.47M Sell
35,352
-3,420
-9% -$271K 0.7% 45
2013
Q4
$3.27M Buy
38,772
+4,270
+12% +$338K 0.94% 23
2013
Q3
$2.66M Sell
34,502
-400
-1% -$28K 0.82% 34
2013
Q2
$2.04M Buy
+34,902
New +$2.1M 0.65% 49

Other funds holding CELG

Arrow Financial's CELG Position: Q4 2019 in Review

Arrow Financial sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 13,997 shares — an estimated $1.39M sold.

Arrow Financial first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $3.97M in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Arrow Financial reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Arrow Financial sold 13,997 Celgene Corp shares in Q4 2019, an estimated $1.39M.
  • Arrow Financial first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Arrow Financial's Celgene Corp position peaked at $3.97M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Arrow Financial's 13F filing for Q4 2019, filed 10 Feb 2020.